Profound Medical ADR drops after pricing $20 mln stock offering
** U.S.-listed shares of Canada's Profound Medical PROF.O
slide 8.2% to $7.62 premarket
** Co's public offering of about 2.7 common shares priced at
$7.50/apiece for gross proceeds of $20 million
** Offering priced at 9.6% discount to stock's last closing
price
** Co expects to use the proceeds to fund the continued
commercialization and development of its medical devices and as
working capital
** Stock down 24% YTD
(Reporting by Medha Singh)
((medha.singh@thomsonreuters.com))